The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial

• Main Authors: Gerloni Valeria (Author), Fasth Anders (Author), Baildam Eileen (Author), Apaz Maria T (Author), Gattorno Marco (Author), Espada Graciela (Author), Woo Patricia (Author), Cuttica Ruben (Author), Petty Ross (Author), Martini Alberto (Author), Lovell Daniel J (Author), Marini Joseph C (Author), Wagner Carrie (Author), Visvanathan Sudha (Author), Lahdenne Pekka (Author), Quartier Pierre (Author), Saurenmann Rotraud (Author), Travers Suzanne (Author), Mendelsohn Alan (Author), Xu Stephen (Author), Giannini Edward H (Author), Ruperto Nicolino (Author)
• Format: Book
• Published: BMC, 2010-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>We evaluated the effect of infliximab on markers of inflammation in patients with juvenile idiopathic arthritis (JIA).</p> <p>Methods</p> <p>In this randomized, placebo-controlled substudy, 122 patients with J...